Read this company snapshot
Daily valuation snapshot
Gelteq Limited Ordinary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.52
- Market capitalization (USD)
- Not reported
- Price / earnings (TTM)
- Not reported
- Price / book
- Not reported
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research GELS in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research GELS in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets and has a strategic alliance with Melbourne Health for the development of maize starch butyrylated, or HAMSB, a compound with the potential to reduce bowel polyp growth which could lower the risk of bowel cancer. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing GELS with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.52 |
| Market capitalization (USD) | Not reported |
| Price / earnings (TTM) | Not reported |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read GELS's valuation metrics
Company size
Market capitalization measures the market value of the company's equity. Read it alongside revenue, earnings and debt when comparing company size.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Gelteq Limited Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about GELS. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow GELS's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.